156
Views
0
CrossRef citations to date
0
Altmetric
Review

Continuous infusion aerosol delivery of prostacyclins during mechanical ventilation: challenges, limitations, and recent advances

ORCID Icon & ORCID Icon
Pages 465-474 | Received 04 Jan 2022, Accepted 30 Mar 2022, Published online: 07 Apr 2022

References

  • Dzierba AL, Abel EE, Buckley MS, et al. A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndrome. Pharmacotherapy. 2014;34(3):279–290.
  • Searcy RJ, Morales JR, Ferreira JA, et al. The role of inhaled prostacyclin in treating acute respiratory distress syndrome. Ther Adv Respir Dis. 2015;9(6):302–312.
  • Pacheco J, Arnold H, Skrupky L, et al. Predictors of outcome in 216 subjects with ARDS treated with inhaled epoprostenol. Respir Care. 2014;59(8):1178–1185.
  • Torbic H, Szumita PM, Anger KE, et al. Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients. J Crit Care. 2013;28(5):844–848.
  • McPeck M, Ashraf S, Cuccia AD, et al. Factors determining continuous infusion aerosol delivery during mechanical ventilation. Respir Care. 2021;66(4):573–581.
  • Moler FW, Hurwitz ME, Custer JR. Improvement in clinical asthma score and PaCO2 in children with severe asthma treated with continuously nebulized terbutaline. J Allergy Clin Immunol. 1988;81(6):1101–1109.
  • Portnoy J, Aggarwal J. Continuous terbutaline nebulization for treatment of severe exacerbations of asthma in children. Ann Allergy. 1988;60(4):368–371.
  • Voss KR, Willsie-Ediger SK, Pyszczynski DR, et al. Description of a delivery method for continuously aerosolized albuterol in status asthmaticus. J Asthma. 1990;27(1):37–39.
  • Colacone A, Wolkove N, Stern E, et al. Continuous nebulization of albuterol (salbutamol) in acute asthma. Chest. 1990;97(3):693–697.
  • Chipps BE, Blackney DA, Black LE, et al. Vortran High Output Extended Aerosol Respiratory Therapy (HEART) for delivery of continuously nebulized terbutaline for the treatment of acute bronchospasm. Pediatr Asthma Allergy Immunol. 1990;4(4):271–277.
  • Moler FW, Johnson CE, Van Laanen C, et al. Continuous versus intermittent nebulized terbutaline: plasma levels and effects. Am J Respir Crit Care Med. 1995;151(3_pt_1):602–606.
  • McPeck M, Hughes K, Tandon R, et al. Aerosol delivery during continuous nebulization. Chest. 1997;111(5):1200–1205.
  • Raabe OG, Wong TM, Wong GB, et al. Continuous nebulization therapy for asthma with aerosols of β2 agonists. Ann Allergy Asthma Immunol. 1998;80(6):488–508.
  • Kelly HW, Keim KA, McWilliams BC. Comparison of two methods of delivering continuously nebulized albuterol. Ann Pharmacother. 2003;37(1):23–26.
  • Berlinski A, Willis JR, Leisenring T. In vitro comparison of 4 large-volume nebulizers in 8 hours of continuous nebulization. Respir Care. 2010;55(12):1671–1679.
  • NHLBI, National Asthma Education and Prevention Program. Expert Panel Report II. Guidelines for the diagnosis and management of asthma. Publication no. 97-4051. Bethesda MD: US Department of Health and Human Services; 1997.
  • Khine H, Fuchs SM, Savile AL. Continuous vs intermittent nebulized albuterol for emergency management of asthma. Acad Emerg Med. 1996;3(11):1019–1024.
  • Tyvaso Inhalation System. Instructions for Use Manual. [cited 2022 Feb 28]. Available from: https://www.tyvaso.com/pdf/TD300_instructions_for_use.pdf
  • Tips to Help Make the Most of Your Treatment with VENTAVIS/Mastering the ABCs of the I-neb Adaptive Aerosol Delivery (AAD®) System. [cited 2022 Feb 28]. Available from: https://www.janssencarepath.com/sites/www.janssencarepath-v1.com/files/ventavis-patient-brochure.pdf
  • Siobal MS, Kallet RH, Pittet J-F, et al. Description and evaluation of a delivery system for aerosolized prostacyclin. Respir Care. 2003;48(8):742–753.
  • Aerogen Solo System Instructions. P/N 30-674 Rev L, 2020, 24–26. [cited 2022 Feb 28]. Available from: https://www.aerogen.com/wp-content/uploads/2020/09/30-674-Rev-L-Aerogen-Solo-System-Instruction-Manual-US_WEB.pdf
  • Anderson AC, Dubosky MN, Fiorino KA, et al., The effect of nebulizer position on aerosolized epoprostenol delivery in an adult lung model. Respir Care. 62(11): 1387–1395. 2017.
  • Smaldone GC. Drug delivery via aerosol systems: concept of “aerosol inhaled.” J Aerosol Med. 1991;4(3):229–235.
  • Ari A, Atalay OT, Harwood R, et al. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care. 2010;55(7):845–851.
  • McPeck M, Lee JA, Cuccia AD, et al. Real-time In Vitro assessment of aerosol delivery during mechanical ventilation. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2022;35(1):32–40.
  • Miller DD, Amin MM, Palmer LB, et al. Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation. Am J Respir Crit Care Med. 2003;168(10):1205–1209.
  • Sidler-Moix A-L, Di Paolo ER, Dolci U, et al. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model. Respir Care. 2015;60(1):38–46.
  • McDermott K, Oakley JG. Droplet size and distribution of nebulized 3% sodium chloride, albuterol, and epoprostenol by phase Doppler particle analyzer. Curr Ther Res Clin Exp. 2021;82. doi:10.1016/j.curtheres.2021.100623.
  • O’Riordan TG, Greco MJ, Perry RJ, et al. Nebulizer function during mechanical ventilation. Am Rev Respir Dis. 1992;145(5):1117–1122.
  • Walmrath D, Schneider T, Pilch J, et al. Aerosolized prostacyclin in adult respiratory distress syndrome. Lancet. 1993;342(8877):961–962.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.